Development of Commercial Manufacturing Processes for Acalabrutinib

IF 3.1 3区 化学 Q2 CHEMISTRY, APPLIED
Paul A. Bethel, Lai Chun Chan, Katie Cooper, Gareth J. Ensor, Jerry Evarts, Rustam Garrey, J. Gair Ford, Daniel Harding, Shaun Hughes, Lucy Jackson, Michael Golden*, Kirsty Millard, Andrew Phillips, Andrew Robbins, David Short, Alex Telford and David T. E. Whittaker, 
{"title":"Development of Commercial Manufacturing Processes for Acalabrutinib","authors":"Paul A. Bethel,&nbsp;Lai Chun Chan,&nbsp;Katie Cooper,&nbsp;Gareth J. Ensor,&nbsp;Jerry Evarts,&nbsp;Rustam Garrey,&nbsp;J. Gair Ford,&nbsp;Daniel Harding,&nbsp;Shaun Hughes,&nbsp;Lucy Jackson,&nbsp;Michael Golden*,&nbsp;Kirsty Millard,&nbsp;Andrew Phillips,&nbsp;Andrew Robbins,&nbsp;David Short,&nbsp;Alex Telford and David T. E. Whittaker,&nbsp;","doi":"10.1021/acs.oprd.2c00304","DOIUrl":null,"url":null,"abstract":"<p >The development of processes to produce the Bruton tyrosine kinase inhibitor, acalabrutinib <b>1</b>, has resulted in improvements to the yield, cycle time, and operability, to realize a robust commercial manufacturing process. A highly accelerated clinical program meant that numerous key process challenges had to be resolved in a short timeframe. Issues are discussed, such as the uncontrolled epimerization of a chiral center and the control of the acalabrutinib <b>1</b> crystallization step, which was prone to oiling. Specifically, work to understand the complex polymorph landscape of a key intermediate (to facilitate resolution of a filtration issue) is described.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"26 12","pages":"3303–3311"},"PeriodicalIF":3.1000,"publicationDate":"2022-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.oprd.2c00304","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

The development of processes to produce the Bruton tyrosine kinase inhibitor, acalabrutinib 1, has resulted in improvements to the yield, cycle time, and operability, to realize a robust commercial manufacturing process. A highly accelerated clinical program meant that numerous key process challenges had to be resolved in a short timeframe. Issues are discussed, such as the uncontrolled epimerization of a chiral center and the control of the acalabrutinib 1 crystallization step, which was prone to oiling. Specifically, work to understand the complex polymorph landscape of a key intermediate (to facilitate resolution of a filtration issue) is described.

Abstract Image

阿卡拉布替尼商业化生产工艺的发展
布鲁顿酪氨酸激酶抑制剂acalabrutinib 1生产工艺的发展,提高了产量、周期时间和可操作性,实现了强大的商业生产工艺。一个高度加速的临床项目意味着许多关键的过程挑战必须在短时间内解决。讨论了不受控制的手性中心外聚化和阿卡拉布替尼1结晶步骤的控制等问题。具体来说,描述了了解关键中间体的复杂多晶型景观的工作(以促进过滤问题的解决)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
14.70%
发文量
251
审稿时长
2 months
期刊介绍: The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信